We describe the synthesis of eight novel putative mono-and bis-DNA intercalators from a common precursor, 6-bromoindolo[1,2-b][2,7]naphthyridine-5,12-dione. Of these new indoloquinones, our data indicate that two are most likely DNA mono-intercalators, but weaker than ethidium bromide, and two others are DNA bis-intercalators. Our indoloquinones are inactive against mammalian topoisomerase II.
Introduction
The antitumor activity and DNA affinity of amino-substituted quinones is well established, [1] [2] [3] [4] and several drugs in this category have seen utility in the cancer clinic; for example, mitomycin (1), 5, 6 ametantrone (2), 7 mitoxantrone (3), 8, 9 pixantrone (4), [10] [11] [12] and WEHI-150 (5) 13, 14 ( Figure 1 ).
Figure 1
We have previously synthesized and utilized the indolo[1,2-b] [2, 7] naphthyridine-5,12-dione (6) ring system to forge several members of the 6H-pyrido [4,3-b] carbazole family of antitumor alkaloids, including ellipticine (7), 9-methoxyellipticine (8) , olivacine (9), 13-oxoellipticine (10), 7,8,9,10-tetrafluoroellipticine (11) , and ellipticine quinone (12) 15-20 ( Figure 2 ). A variation of our method allowed for the synthesis of 10H-pyrido [2,3-b] carbazoles (13) 21 and 6,11-disubstituted-benzo [b] carbazoles (14) . 22 The shape similarity of quinone (6) with that of ellipticine quinone (12) and calothrixin B (15) , both of which display antitumor activity, [23] [24] [25] suggested that it would be fruitful to examine indoloquinone 6 and its amino-substituted derivatives for DNA binding, given the known enhancement of DNA binding and resulting biological activity imparted by the alkylamino side chains in antitumor quinones 2-5.
Scheme 2
Interestingly, the reaction of 24 with hot dimethylformamide (DMF) produced 5-(methylamino)indolo [1,2-b] [2, 7] naphthyridine-6,11-dione (17d) in 86% yield (Scheme 2). This peculiar reaction was discovered during attempts to displace bromide from 24 with 2-amino-2-methyl-1,3-propanediol 30 in hot DMF, since milder conditions (THF, rt) were unproductive. To confirm that the methylamino group had come from DMF rather than via the decomposition of 2-amino-2-methyl-1,3-propanediol, a solution of 24 was heated in DMF for 24 hours; once, again, there was a clean conversion to 17d. This phenomenon had been observed twenty years earlier by Lord and Peters, 31 who observed that heating 1-chloroanthraquinone for 32 hours in DMF at reflux afforded a mixture of 1-dimethylaminoanthraquinone (25) and 1-methylaminoanthraquinone (26) . Moreover, 25 was demethylated to 26 by additional heating in DMF for 73 hours. In contrast, 2-chloroanthraquinone gave only 2-dimethylaminoanthraquinone in refluxing DMF. These observations are wholly consistent with a demethylation mechanism involving assistance by the neighboring carbonyl group as shown for the formation of 17d from 24 (Scheme 3).
Our results of DNA affinity studies for 17a-d and 18a-d are summarized in Table 1 . The change in DNA melting, ∆T m , is the change in the thermal denaturation of DNA by a drug as a result of intercalation. 34 From these results, it can be seen that compounds 17b and 17c are intercalators, although less effective when compared to a powerful intercalator such as the aminoacridine, quinacrine, which has a ∆T m value of 24.9.
34
The other experiment was to determine the slope of the calf thymus viscometric titration. When a drug intercalates into DNA, the DNA helix lengthens. Thus, the line of concern here is the ratio of the increase in DNA contour length versus the drug/nucleotide ratio. 34 Unfortunately, in further tests, neither of these compounds exhibited any activity against mammalian topoisomerase II, which are enzymes that cause doublestrand breaks in DNA, cause the DNA to unwind, and reseal the breaks. 35 They are believed to be necessary for replication, since the helical winding of the DNA must be released to allow strand splitting in replication. Thus, it is currently believed that topoisomerase activity is crucial for useful anticancer activity. 35 We find that 17a-d have no activity against mammalian topoisomerase II at a drug concentration of 100 µM. Poly GC is sonicated poly(dG-dC) with alternating GCGCGC on both strands.
Conclusions
We have synthesized eight novel indoloquinones, 17a-d and 18a-d for DNA binding studies. Of these, 17a and 17d do not bind to DNA as evidenced by the calf thymus DNA assay, suggesting that the pyridine ring system alone is insufficiently basic to become protonated in the presence of the polyphosphates of DNA. Moreover, as might be expected, the exocyclic amino group is rendered less basic by the C-5 carbonyl group (vinylogous amide). In contrast, our data indicate that 17b and 17c are probably mono-intercalators. These two quinones show a binding profile similar to other DNA intercalators, and they exhibit a GC preference. By comparison to ethidium bromide, these two compounds are somewhat weaker intercalators. In contrast, indoloquinones 18b and 18c are likely bis-intercalators, since the high CT for 18b and its biphasic nature suggests a double intercalator. The lesser DNA affinity of 18c is probably imparted by the less electronegative oxygen atoms in the tether. Our eight new compounds, 17a-d and 18a-d, will serve in future biological studies.
Experimental Section
General. Melting points were determined on a Büchi 510 apparatus and are uncorrected. Infrared (IR) spectra were recorded on a Perkin-Elmer 599 spectrometer and are referenced to the 1601 cm -1 band of polystyrene. 1 H NMR (300 MHz) and 13 C NMR (75 MHz) were recorded on a Varian XL-300 multinuclear Fourier transform spectrometer. Unitary resolution mass spectra (MS) were obtained on a Finnigan 4023 GC/MS system. High resolution mass spectra (HRMS) were recorded at the National Institutes of Health regional facility at the Massachusetts Institute of Technology. Ultraviolet (UV) spectra were recorded on a Hewlett Packard 8451A diode array spectrophotometer. Elemental analyses were performed by Atlantic Microlab Inc., Norcross, GA. Analytical thin-layer chromatography (TLC) was performed on precoated Silica Gel 60 F 254 plates from EM Reagents. Visualization was accomplished with 254 and 365 nm UV light, iodine vapor, ceric ammonium sulfate spray (3% in 10% sulfuric acid) or "van Urk's reagent" spray (p-dimethylaminobenzaldehyde in ethanolic sulfuric acid). Flash chromatography was performed with EM Reagents Silica Gel 60 (230-400 mesh). All reactions were performed under a static head of predried (CaSO 4 tower) nitrogen or argon in glassware that had been dried for at least 1 h at 135 °C. Benzenesulfonyl chloride and 3,4-pyridinedicarboxylic anhydride were distilled prior to use.
3-Bromo-1-(phenylsulfonyl)indole (21).
To a stirred solution of 1-(phenylsulfonyl)indole 36 (20) 
3-Bromo-1-(phenylsulfonyl)indol-2-yl 3-carboxy-4-pyridyl ketone (22).
To a solution of lithium diisopropylamide (7.14 mmol) prepared from diisopropylamine (1.00 mL, 7.14 mmol) and n-butyllithium ( 
6-Dimethylaminoindolo[1,2-b][2,7]naphthyridine-5,12-dione (17a).
To a solution of 24 (100 mg, 0.31 mmol) in THF (25 mL) was added excess Me 2 NH (25% aqueous solution, 20 mL). The mixture was stirred at rt for 6 h, during which time the solution became bright orange. The solution was poured into EtOAc (100 mL) and washed with saturated aqueous NaHCO 3 (2 x 50 mL), H 2 O (2 x 50 mL) and brine (50 mL), then dried (Na 2 SO 4 ) and concentrated to give an orange powder. Recrystallization from THF-hexane gave 73 mg (82%) of 17a as small orange needles: mp 240-242 °C; IR (CHCl 3 
6-[N-[2-(Dimethylamino)ethyl]methylamino]indolo[1,2-b][2,7]naphthyridine-5,12-dione (17b).
To a solution of 24 (65 mg, 0.20 mmol) in THF (5 mL) was added excess N,N,N'-trimethylethylenediamine (0.10 mL, 0.78 mmol). The mixture was refluxed for 1 h, during which time the solution became dark orange. The solution was cooled and poured into EtOAc (50 mL) and washed with saturated aqueous NaHCO 3 (2 x 25 mL), H 2 O (2 x 25 mL) and brine (25 mL), then dried (Na 2 SO 4 ) and concentrated to give a red powder. Recrystallization from CH 2 Cl 2 -hexane gave 57 mg (83%) of 17b as short red needles: mp 129-131 °C; IR (CHCl 3 12-dione (17c) . To a solution of 24 (56 mg, 0.17 mmol) in THF (5 mL) was added excess 3-diethylaminopropylamine (0.10 mL, 0.63 mmol). The mixture was refluxed for 1 h, during which time the solution became dark orange. The solution was cooled and poured into EtOAc (50 mL) and washed with saturated aqueous NaHCO 3 (2 x 25 mL), H 2 O (2 x 25 mL) and brine (25 mL), and then dried (Na 2 SO 4 ) and concentrated to give an orange semi-solid. Recrystallization from CH 2 Cl 2 -hexane gave 42 mg (66%) of 17c as an orange powder: mp 102-103 °C; IR (CHCl 3 ) 3450, 2980, 2940, 2820 6-Methylaminoindolo[1,2-b][2,7]naphthyridine-5,12-dione (17d). A solution of 24 (0.102 g, 0. 31 mmol) in DMF (20 mL) was heated at 130 °C for 24 h. The dark orange red solution was cooled and poured into saturated aqueous NaHCO 3 (50 mL) and extracted with CH 2 Cl 2 (3 x 25 mL). The combined organic phase was washed with H 2 O (2 x 50 mL) and brine, dried (Na 2 SO 4 ), concentrated in vacuo, and dried for 12 h at 60 °C in vacuo to give a brick-red solid. Recrystallization from CH 2 Cl 2 -hexane gave 0.073 g (86%) of 17d as a dark red powder: mp 278-280 °C; IR (CHCl 3 ) 3400, 2930, 2860, 1720, 1675, 1635, 1535, 1450 (27) . To a solution of 24 (50 mg, 0.15 mmol) in DMF (5 mL) was added (n-Bu) 4 NCl (50 mg, 0.18 mmol). The mixture was stirred at rt for 12 h and then poured into H 2 O (25 mL). The precipitate was collected by filtration, dried and recrystallized from CH 2 Cl 2 -hexane to yield 29 mg (71%) of 27 that was identical with an authentic sample by TLC, mp, and MS: mp 220-221 °C (lit. To a solution of 24 (0.50 g, 1.5 mmol) in THF (25 mL) was added 3,3'-diamino-N-methyldipropylamine (0.10 g, 0.70 mmol). The mixture was refluxed for 6 h, then cooled, poured into saturated aqueous sodium bicarbonate solution (100 mL) and extracted with CH 2 Cl 2 (3 x 50 mL). The combined organic phase was washed with saturated aqueous sodium bicarbonate solution (50 mL), water (50 mL), and saturated aqueous sodium chloride solution (50 mL), then dried (Na 2 SO 4 ) and adsorbed onto silica gel. Elution first with EtOAc then acetone then 16:3:1 acetone-MeOH-TEA yielded 0.19 g (43%) of 18b as an orange-red powder: mp 170-175 °C (dec); 1 18c) . To a solution of 24 (0.50 g, 1.5 mmol) in THF (25 mL) was added 4,9-dioxa-1,12-dodecanediamine (0.15 mL, 0.70 mmol). The mixture was refluxed for 6 h, then cooled, poured into saturated aqueous sodium bicarbonate solution (100 mL) and extracted with CH 2 Cl 2 (3 x 50 mL). The combined organic phase was washed with saturated aqueous sodium bicarbonate solution (50 mL), water (50 mL), and saturated aqueous sodium chloride solution (50 mL), then dried (Na 2 SO 4 ) and adsorbed onto silica gel. Elution first with EtOAc, then acetone, then 16 
